Study of BGM0504 tablets in overweight or obese adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational tablet called BGM0504 for weight management in adults with overweight or obesity but without diabetes. It looks at how the drug works in your body and how safe it is over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are overweight (BMI 27.0-29.9) with a related health condition like prediabetes or high blood pressure, OR you have obesity (BMI 30.0-40.0).
- Your weight has been stable (within 5%) for the past 12 weeks without intentional weight loss.
- You have not used GLP-1 drugs (like Ozempic or Wegovy) in the last 12 weeks.
- You have not taken any weight-loss medications in the last 12 weeks.
- You do not have type 1 or type 2 diabetes.
- You do not have a history of pancreatitis or severe allergies to multiple drugs or foods.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental pill, BGM0504, to see if it helps overweight or obese adults lose weight safely. Participants will take the pill while continuing their usual diet and exercise routine.
This trial tests an investigational drug, BGM0504, for people recently diagnosed with type 2 diabetes who also have obesity. It aims to see if the drug can help control blood sugar and support weight loss.
This study tests an investigational drug called GS-4571 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects the body and whether it might help with weight and blood sugar control.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
This trial tests a new medication, GL0034, to see if it helps with weight loss and blood sugar control in people with type 2 diabetes who are overweight. Participants must already be taking metformin and not using other diabetes drugs.
Hear when a new Non-diabetic Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.